Imeglimin is used in the treatment of type 2 diabetes mellitus.
Imeglimin works by stimulating insulin secretion in a glucose-dependent manner, which helps lower blood sugar levels.
Common side effects of Imeglimin include hypoglycemia (low blood glucose level) and constipation.